Home Cart 0 Sign in  
X

[ CAS No. 4841-22-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4841-22-9
Chemical Structure| 4841-22-9
Chemical Structure| 4841-22-9
Structure of 4841-22-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4841-22-9 ]

Related Doc. of [ 4841-22-9 ]

Alternatived Products of [ 4841-22-9 ]

Product Details of [ 4841-22-9 ]

CAS No. :4841-22-9 MDL No. :MFCD00063317
Formula : C9H9ClO3 Boiling Point : -
Linear Structure Formula :- InChI Key :OSGZHKYFZSNKRI-UHFFFAOYSA-N
M.W : 200.62 Pubchem ID :96277
Synonyms :

Calculated chemistry of [ 4841-22-9 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 4
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 48.84
TPSA : 35.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.08 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.39
Log Po/w (XLOGP3) : 2.04
Log Po/w (WLOGP) : 1.89
Log Po/w (MLOGP) : 1.94
Log Po/w (SILICOS-IT) : 2.22
Consensus Log Po/w : 2.1

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.45
Solubility : 0.717 mg/ml ; 0.00358 mol/l
Class : Soluble
Log S (Ali) : -2.41
Solubility : 0.773 mg/ml ; 0.00385 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.24
Solubility : 0.115 mg/ml ; 0.000575 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.78

Safety of [ 4841-22-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4841-22-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4841-22-9 ]
  • Downstream synthetic route of [ 4841-22-9 ]

[ 4841-22-9 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 96-32-2 ]
  • [ 106-48-9 ]
  • [ 4841-22-9 ]
YieldReaction ConditionsOperation in experiment
96.5%
Stage #1: With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.0333333 h;
Stage #2: at 80℃; for 4 h;
To a solution of 4-chlorophenol (15 g, 1 16.67 mmol, 1 equiv) in DMF (100 ml_) at room temperature was added anhydrous potassium carbonate (24.15 g, 175.01 mmol, 1 .5 equiv) portionwise. After stirring for 2 minutes, methyl-2-bromoacetate (13.3 ml_, 140.01 mmol, 1 .2 equiv) was added. The reaction mixture was heated at 80 °C for 4 h. After consumption of the starting material (TLC, 5 percent EtOAc in hexane), the reaction mixture was cooled to room temperature, diluted with water (100 ml_) and extracted with EtOAc (2 x 100 ml_). The combined organic layer was washed with brine solution (50 ml_), dried over anhydrous sodium sulphate, filtered and concentrated en vacuo to give the crude product. The crude product was purified by flash column chromatography (Combiflash) using a silica gel column and the product was eluted at 15percent ethyl acetate in hexane. Fractions containing product were concentrated to give methyl 2-(4- chlorophenoxy)acetate (22.5 g, 96.5percent yield) as pale yellow liquid. 1H NMR (400 MHz, CDC ): δ ppm 3.67 (s, 3 H), 4.78 (s, 2 H), 6.91 - 6.95 (m, 2 H), 7.28 - 7.32 (m, 2 H).
96.5%
Stage #1: With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.0333333 h;
Stage #2: at 80℃; for 4 h;
To a solution of 4-chlorophenol (15 g, 1 16.67 mmol, 1 equiv) in DMF (100 mL) at room temperature was added anhydrous potassium carbonate (24.15 g, 175.01 mmol, 1 .5 equiv ) portionwise. After stirring for 2 minutes, methyl-2-bromoacetate (13.3 mL, 140.01 mmol, 1 .2 equiv) was added. The reaction mixture was heated at 80 °C for 4 h. After consumption of the starting material (TLC, 5 percent EtOAc in hexane), the reaction mixture was cooled to room temperature, diluted with water (100 mL) and extracted with EtOAc (2 x 100 mL). The combined organic layer was washed with brine solution (50 mL), dried over anhydrous sodium sulphate, filtered and concentrated en vacuo to give the crude product. The crude product was purified by flash column chromatography (Combiflash) using a silica gel column and the product was eluted at 15percent ethyl acetate in hexane. Fractions containing product were concentrated to give methyl 2-(4-chlorophenoxy)acetate (22.5 g, 96.5percent yield) as pale yellow liquid. NMR (400 MHz, CDCI3): δ ppm 3.67 (s, 3 H), 4.78 (s, 2 H), 6.91 - 6.95 (m, 2 H), 7.28 - 7.32 (m, 2 H).
90% With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 24 h; General procedure: To a stirred solution of phenol (1 mmol) in DMF (3 mL) were added methyl bromoacetate (0.1 mL, 1 mmol) and K2CO3 (207 mg, 1.5 mmol), and the resulting mixture was heated at 80 °C for 24 h. After cooling, the reaction mixture was diluted with EtOAc, and filtered by celite pad. The filtrate was evaporated, and the residue was chromatographed on silica gel (15 g, hexane : acetone = 50 : 1 ~ 40 : 1) to give corresponding ether.
Reference: [1] Patent: WO2017/212423, 2017, A1, . Location in patent: Page/Page column 71; 72
[2] Patent: WO2017/212425, 2017, A1, . Location in patent: Page/Page column 68-69
[3] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 16, p. 3732 - 3735
[4] Chemistry - A European Journal, 2017, vol. 23, # 50, p. 12096 - 12099
[5] Chemistry - A European Journal, 2014, vol. 20, # 18, p. 5492 - 5500
  • 2
  • [ 96-34-4 ]
  • [ 106-48-9 ]
  • [ 4841-22-9 ]
Reference: [1] Synthetic Communications, 2005, vol. 35, # 13, p. 1759 - 1764
[2] Synthetic Communications, 1984, vol. 14, # 1, p. 69 - 76
[3] Journal of Chemical Research, 2005, # 7, p. 432 - 433
[4] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2006, vol. 45, # 5, p. 1312 - 1314
[5] Journal of Chemical Research, 2010, # 8, p. 452 - 454
[6] Journal of the Chemical Society of Pakistan, 2016, vol. 38, # 5, p. 974 - 980
[7] Molecules, 2017, vol. 22, # 1,
  • 3
  • [ 67-56-1 ]
  • [ 122-88-3 ]
  • [ 4841-22-9 ]
Reference: [1] Synthetic Communications, 2004, vol. 34, # 3, p. 377 - 382
[2] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1981, vol. 20, # 7, p. 629 - 631
[3] Journal of the Indian Chemical Society, 1981, vol. 58, # 11, p. 1082 - 1083
[4] Journal of the Chemical Society, 1922, vol. 121, p. 1603
[5] Synthetic Communications, 2008, vol. 38, # 23, p. 4107 - 4115
  • 4
  • [ 67-56-1 ]
  • [ 51-68-3 ]
  • [ 4841-22-9 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1980, vol. 28, # 3, p. 779 - 782
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4841-22-9 ]

Aryls

Chemical Structure| 588-22-7

[ 588-22-7 ]

2-(3,4-Dichlorophenoxy)acetic acid

Similarity: 0.92

Chemical Structure| 7417-89-2

[ 7417-89-2 ]

2-(4-Chloro-2-hydroxyphenoxy)acetic acid

Similarity: 0.88

Chemical Structure| 575-90-6

[ 575-90-6 ]

2-(2,6-Dichlorophenoxy)acetic acid

Similarity: 0.81

Chemical Structure| 1165-91-9

[ 1165-91-9 ]

Bis(2,4,6-trichlorophenyl) oxalate

Similarity: 0.79

Chemical Structure| 3547-07-7

[ 3547-07-7 ]

4-(4-Chlorophenoxy)butanoic acid

Similarity: 0.77

Chlorides

Chemical Structure| 588-22-7

[ 588-22-7 ]

2-(3,4-Dichlorophenoxy)acetic acid

Similarity: 0.92

Chemical Structure| 7417-89-2

[ 7417-89-2 ]

2-(4-Chloro-2-hydroxyphenoxy)acetic acid

Similarity: 0.88

Chemical Structure| 575-90-6

[ 575-90-6 ]

2-(2,6-Dichlorophenoxy)acetic acid

Similarity: 0.81

Chemical Structure| 1165-91-9

[ 1165-91-9 ]

Bis(2,4,6-trichlorophenyl) oxalate

Similarity: 0.79

Chemical Structure| 3547-07-7

[ 3547-07-7 ]

4-(4-Chlorophenoxy)butanoic acid

Similarity: 0.77

Ethers

Chemical Structure| 588-22-7

[ 588-22-7 ]

2-(3,4-Dichlorophenoxy)acetic acid

Similarity: 0.92

Chemical Structure| 7417-89-2

[ 7417-89-2 ]

2-(4-Chloro-2-hydroxyphenoxy)acetic acid

Similarity: 0.88

Chemical Structure| 575-90-6

[ 575-90-6 ]

2-(2,6-Dichlorophenoxy)acetic acid

Similarity: 0.81

Chemical Structure| 3547-07-7

[ 3547-07-7 ]

4-(4-Chlorophenoxy)butanoic acid

Similarity: 0.77

Chemical Structure| 21567-18-0

[ 21567-18-0 ]

4-(4-Chlorophenoxy)phenol

Similarity: 0.77

Esters

Chemical Structure| 1165-91-9

[ 1165-91-9 ]

Bis(2,4,6-trichlorophenyl) oxalate

Similarity: 0.79

Chemical Structure| 2065-23-8

[ 2065-23-8 ]

Methyl 2-phenoxyacetate

Similarity: 0.76

Chemical Structure| 2044706-76-3

[ 2044706-76-3 ]

Methyl 2-(3,5-dichlorophenoxy)-4-methylpentanoate

Similarity: 0.73

Chemical Structure| 13078-21-2

[ 13078-21-2 ]

Ethyl 2-(2-methoxyphenoxy)acetate

Similarity: 0.73

Chemical Structure| 99186-63-7

[ 99186-63-7 ]

Ethyl 2-(2-hydroxyphenoxy)acetate

Similarity: 0.73